BDmRNA-C-02

N/A

Report date: 2024/08/29 17:07:00

Base Information

Drug NameBDmRNA-C-02
Drug Alias NameBDmRNA-C-02
ClassificationCell and gene therapy > Gene therapy > mRNA
Mechanisms of ActionGene expression modulatorsVascular endothelial growth factor A inhibitors
TargetsVascular endothelial growth factor A
Therapy Area/IndicationsMacular Degeneration
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesShanghai BDgene Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesShanghai BDgene Co Ltd
Inactive CompaniesN/A
Active IndicationsMacular Degeneration
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A